Nutraceuticals producer Vitiva Slovenia has reported sales growth of 225% for the first half of 2006. said most of its sales activity was focused on traditional markets for rosemary extract products as well as a wide range of new applications requiring odourless rosemary extract.

“We’re continuing to propel Vitiva’s business with breakthrough innovations and excellent in-market execution,” said CEO Ohad Cohen. “This is combined with tremendous progress in plant investments and cost reduction. Large investments are also being made in applications and in the development of specific solutions for a completely new range of applications — ones that previously lacked rosemary extract.” 

Vitiva added that the significant growth was also the result of several strategic moves, including joint operations with leading pharmaceutical companies and the establishment of a new sales network in Europe and North America.

The company said it expected to exceed its growth target for 2006 and meet its goals for 2007.